flow semaglutide clinical trial New Science Suggests Improves CV Outcomes Beyond Weight Loss FLOW trial Ozempic® (semaglutide injection)
Description
Patients should work closely with their healthcare team to achieve and maintain individualised HbA1c targets as recommended by NICE guideline NG28 , typically aiming for 48 mmol/mol (6.5%) for adults on lifestyle measures or a single drug not associated with hypoglycaemia , or 53 mmol/mol (7.0%) for those on drugs associated with hypoglycaemia or on multiple therapies
This is where the psychological component of direction and confidence becomes vital
This is one of the most common and costly mistakes men make early in treat
Monitor Your Micros: Sometimes, rapid weight loss leads to nutrient gaps
